Published November 2007 | Version v1
Journal article

Radioinduced pulmonary fibrosis: prospective study of clinical, dosimetric and biological predictive factors after conformal irradiation of non at small cells bronchi carcinomas

  • 1. Centre Leon-Berard, 69 - Lyon (France)
  • 2. Hopital Louis-Pradel, 69 - Lyon (France)
  • 3. Hopital de la Croix-Rousse, 69 - Lyon (France)
  • 4. Hopital Saint-Luc-Saint-Joseph, 69 - Lyon (France)
  • 5. Hopital de Villefranche, 69 - Villefranche s/Saone (France)
  • 6. Hopital Edouard-Herriot, 69 - Lyon (France)

Description

This broad prospective study confirms the contribution of dosimetry factors ( pulmonary average dose, V10 to V50) in the predictive part for the delayed radioinduced fibrosis. Contrary to the acute radioinduced pneumopathy, no significant relationship has been underlined between the variations of cytokines and the delayed radioinduced fibrosis risk. (N.C.)

Availability note (English)

Available from doi: <http://dx.doi.org/10.1016/j.canrad.2007.09.116

Additional details

Additional titles

Original title (French)
Fibroses radiques pulmonaires: etude prospective des facteurs predictifs cliniques, dosimetriques et biologiques apres irradiation conformationnelle des carcinomes bronchiques non a petites cellules

Identifiers

Publishing Information

Journal Title
Cancer Radiotherapie
Journal Volume
11
Journal Issue
no.6-7
Journal Page Range
p. 420
ISSN
1278-3218
CODEN
CARAFC

Conference

Title
18. national congress of the French Society of Oncology Radiotherapy
Original Conference Title
18. congres national de la Societe Francaise de Radiotherapie Oncologique
Dates
28-30 Nov 2007
Place
Paris (France)

INIS

Country of Publication
France
Country of Input or Organization
France
INIS RN
39060170
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference
Descriptors DEI
CARCINOMAS; DOSIMETRY; FIBROSIS; IRRADIATION; LYMPHOKINES; RADIOINDUCTION; RESPIRATORY SYSTEM DISEASES
Descriptors DEC
DISEASES; GROWTH FACTORS; MITOGENS; NEOPLASMS; ORGANIC COMPOUNDS; PATHOLOGICAL CHANGES; PROTEINS